ResMed| · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← RMD

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q4	2026-06-30	1.46	+8.6%	58.8%	0.45	0.38	26.2%	0.40	2.64	0.20	0.09
FY2026 Q3	2026-03-31	1.43	+10.8%	62.2%	0.50	0.40	27.9%	0.52	2.74	0.18	0.09
FY2026 Q2	2025-12-31	1.42	+11.0%	61.8%	0.49	0.39	27.6%	0.31	2.68	0.18	0.09
FY2026 Q1	2025-09-30	1.34	+9.1%	61.5%	0.45	0.35	26.1%	0.41	2.37	0.15	0.09
FY2025 Q4	2025-06-30	1.35	+10.2%	60.8%	0.45	0.38	28.2%	0.51	2.58	0.10	0.08
FY2025 Q3	2025-03-31	1.29	+7.9%	59.3%	0.43	0.37	28.3%	0.56	2.48	0.08	0.08
FY2025 Q2	2024-12-31	1.28	+10.3%	58.6%	0.42	0.34	26.9%	0.29	2.34	0.07	0.08
FY2025 Q1	2024-09-30	1.22	+11.1%	58.6%	0.39	0.31	25.4%	0.31	2.11	0.05	0.08
FY2024 Q4	2024-06-30	1.22	+9.0%	58.5%	0.38	0.29	23.9%	0.42	1.97	0.05	0.07
FY2024 Q3	2024-03-31	1.20	+7.2%	57.9%	0.37	0.30	25.1%	0.38	2.04	0.05	0.07
FY2024 Q2	2023-12-31	1.16	+12.5%	55.6%	0.28	0.21	18.0%	0.25	1.42	0.05	0.07
FY2024 Q1	2023-09-30	1.10	+16.0%	54.4%	0.29	0.22	19.9%	0.26	1.49	0.00	0.07
FY2023 Q4	2023-06-30	1.12	—	55.0%	0.28	0.23	20.5%	0.20	1.55	0.00	0.06
FY2023 Q3	2023-03-31	1.12	—	55.3%	0.30	0.23	20.8%	0.25	1.58	0.00	0.06
FY2023 Q2	2022-12-31	1.03	—	56.1%	0.28	0.22	21.8%	0.10	1.53	—	0.06
FY2023 Q1	2022-09-30	0.95	—	56.9%	0.28	0.21	22.1%	0.02	1.43	—	0.06

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.